Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study
with oral GLP-1, absorption depends heavily on fasting state and timing
Medical Weight Loss: A Science-Based Approach That Actually Works Medical weight loss represents a fundamental shift in how we approach weight management
In a phase 3, multicenter, double-blind, placebo-controlled trial of once weekly exenatide versus placebo, no significant between-group differences were observed on the Unified Dyskinesia Rating Scale [34]
Yes, but monitor for hypoglycemia, especially when combined with insulin or sulfonylureas